Southwest Center in Arizona Applauds the new Breakthrough in Telehealth, the MedPod by Daya Medicas for AIDS Patients

MIAMI, FL, December 17, 2010 (Press-News.org) Daya Medicals, Inc. presents its game-changing patient-centered medication dispensing and data coordinating "cloud" based hub, the MedPod. The MedPod unit designed by Daya Medicals, Inc.is small enough to fit in the palm of a hand, is mobile, and simple to use. All units are pre stocked with prescribed patient-customized drug dosages (prescribed medication) and patient reminder alerts, with light and sound, before being shipped to the patient's door. The unit does not require any wifi connection as it uses a cellular technology for communication. Hi-tech tracking allows the physician and any HIPAA approved need-to-know individual in the patient's ecosystem (and/or caregiver) to connect with the patient on a real time basis. Patients maintain compliance with medications and dosing while remaining in control of their home health care.

"Southwest Center for HIV/AIDS is focusing attention on implementing the National HIV/AIDS strategy by reducing new HIV infections, increasing access to care, improving health outcomes for people living with HIV, and reducing HIV-related health disparities among underserved populations," noted Carol Poore, president and CEO of Southwest Center in Arizona. "The portable MedPod real-time device helps those impacted by HIV/AIDS stay on track with their prescribed medication regimen. This type of personalized, convenient technology can empower our clients to actively pursue their wellness and chronic disease management," continues Poore.

The MedPod is designed to cut healthcare costs and risks while increasing patient responsibility, compliance, communication, benefits of home healthcare, control, and peace of mind. The MedPod's inherent telehealth capabilities empower management of fraud and lowers costs. Due to its effective and efficient variety of applications and benefits, initial testing of Daya Medicals, Inc.'s MedPod has already received rave reviews and prescribers from well respected healthcare providers, government officials, economists, unions, insurance companies, human resources specialists, doctors, hospitals, among others.

Daya Medicals, Inc. plans to manufacture the medication cartridges at their new facility, the life sciences and technology park on campus at the University of Miami, located at 1951 NW 7th Avenue in Miami, initially creating close to 60 jobs in the (initial) introductory phase. Chief Executive and Medical Officer Dr. Kanti Daya says, "The MedPod is unique in that it addresses today's concerns for cost and quality control with healthcare reform as well as the growing and future needs of general health care. With the expanding growth of the market, it's harder to address both patient and health care provider needs. A unit like MedPod allows patients to help themselves and creates a win-win for all parties, building stronger and more synergistic relationships." Daya adds that additional benefits include insurance incentives, lower drug confusion and abuse, and increased lines of communication between caregiver and patient, eliminating errors, fraud, and waste.

About Daya Medicals, Inc.

Daya Medicals, Inc. is a Pharmaceutical Company with the Prime Directive of Sanitas Pro Omnibus - Health for all. The company empowers and vigorously partners with patients to address diseases and mitigate debility by ameliorating the experiences of aging. These objectives are achieved by minimizing the invasiveness of treatments and enhancing compliance, by expanding access to and integration of data and information on a patient customized basis, by utilizing patient customized clinical information to drive care delivery and minimize errors, and by recognizing and reducing the role of cost to customized patient outcomes. DayaMed has developed next generation technology to achieve these objectives.

The company is additionally fortified with three proprietary products, CarvasinTM - Cardiovascular and Cerebrovascular pathology therapeutic regimen, (Heart Disease Protocol Medication), DST - a Syphilis Screening Test utilized by the US DoD, and The D-Mantoux Tuberculosis Test with two FDA approvals and a third eminently pending Phase One Trials. The portfolio of products includes cardiovascular products, Infectious Disease products, over two hundred generics, laboratory equipment and Diagnostic products.

For more information, visit http://www.dayamed.com or contact Dana Klein at 954-923-4343

About the Southwest Center for HIV/AIDS

According to state health records, more than 14,000 individuals have been diagnosed with HIV/AIDS in Arizona; 70 percent are men, and 70 percent of those living with HIV/AIDS live in Maricopa County.

The Southwest Center for HIV/AIDS is Arizona's only AIDS service organization providing a unique combination of prevention, research and wellness support to serve 70 percent of Arizona's nearly 14,000 residents infected with HIV/AIDS who live in Maricopa County. Since 1988, Southwest Center has been on the front lines addressing a steady increase in the demand for HIV/AIDS testing and counseling, prevention education, wellness support services, and clinical trials to help Arizona men, women and teens impacted by the disease.

The Southwest Center's mission is to lead the fight against HIV/AIDS by preventing the disease, by improving the quality of life for those who are impacted, and by contributing to worldwide research. Southwest Center's clinical trials research program has helped bring 29 of the 30 available HIV/AIDS drugs to market. As our Valley continues to grow, the cases of HIV/AIDS continue to grow as well. In 2010, Southwest Center's HIV testing program has grown by 32 percent over the prior year. For more information, contact: 602-307-5330 or visit http://www.swhiv.org.

For more information, contact Dana Klein at 954-923-4343 or DKlein@dkmc.com